Back to results
CompletedPhase 2

Safety and Efficacy of THN102 in Patients With Parkinson's Disease and Excessive Daytime Sleepiness

NCT03624920

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of Kansas Medical Center

Kansas City, Kansas, United States

+33 additional locations

View on ClinicalTrials.gov
Safety and Efficacy of THN102 in Patients With Parkinson's Disease and Excessive Daytime Sleepiness — TrialFind